Yuan, J., Fan, J., Liu, T., Yuan, X., Zhao, H., Song, Z., Li, N., Gu, Y., Zhang, Y., Sun, B., Du, Y., Enxiao, L., He, Y., Shen, L. (2026). First-in-human phase I/II study of a highly selective FGFR2 inhibitor 3HP-2827 in patients with advanced solid tumors harboring FGFR2 alterations.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3114